相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Measurement of hypoxia in the lung in idiopathic pulmonary fibrosis: a matter of control
Pierre-Simon Bellaye et al.
EUROPEAN RESPIRATORY JOURNAL (2022)
Partial ligand shielding nanoparticles improve pancreatic ductal adenocarcinoma treatment via a multifunctional paradigm for tumor stroma reprogramming
Ting Zhao et al.
ACTA BIOMATERIALIA (2022)
Nanoparticle targeting of de novo profibrotic macrophages mitigates lung fibrosis
Abhalaxmi Singh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)
Inhaled deep eutectic solvent based-nanoemulsion of pirfenidone in idiopathic pulmonary fibrosis
Ji-Hyun Kang et al.
JOURNAL OF CONTROLLED RELEASE (2022)
Integrated metabolomics revealed the fibromyalgia-alleviation effect of Mo2C nanozyme through regulated homeostasis of oxidative stress and energy metabolism
Dingkun Zhang et al.
BIOMATERIALS (2022)
Pathological collagen targeting and penetrating liposomes for idiopathic pulmonary fibrosis therapy
Ming-Yuan Yang et al.
JOURNAL OF CONTROLLED RELEASE (2022)
A nanotherapeutic strategy to overcome chemotherapeutic resistance of cancer stem-like cells
Shiyang Shen et al.
NATURE NANOTECHNOLOGY (2021)
Emerging drug delivery strategies for idiopathic pulmonary fibrosis treatment
Moez Ghumman et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2021)
Co-delivery of siPTPN13 and siNOX4 via (myo)fibroblast-targeting polymeric micelles for idiopathic pulmonary fibrosis therapy
Jiwei Hou et al.
THERANOSTICS (2021)
Pirfenidone: Molecular Mechanisms and Potential Clinical Applications in Lung Disease
Saleela M. Ruwanpura et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2020)
Inhalation of lung spheroid cell secretome and exosomes promotes lung repair in pulmonary fibrosis
Phuong-Uyen C. Dinh et al.
NATURE COMMUNICATIONS (2020)
Monocyte-derived multipotent cell delivered programmed therapeutics to reverse idiopathic pulmonary fibrosis
Xin Chang et al.
SCIENCE ADVANCES (2020)
Nanoapproaches to Modifying Epigenetics of Epithelial Mesenchymal Transition for Treatment of Pulmonary Fibrosis
Melissa Skibba et al.
FRONTIERS IN PHARMACOLOGY (2020)
Palmitic acid-modified bovine serum albumin nanoparticles target scavenger receptor-A on activated macrophages to treat rheumatoid arthritis
Ting Gong et al.
BIOMATERIALS (2020)
A new tandem peptide modified liposomal doxorubicin for tumor ecological therapy
Ting Zhao et al.
NANOSCALE (2020)
Hypoxia and transforming growth factor beta 1 regulation of long non-coding RNA transcriptomes in human pulmonary fibroblasts
Lakmini K. Senavirathna et al.
PHYSIOLOGICAL REPORTS (2020)
A Hypoxia-Responsive Albumin-Based Nanosystem for Deep Tumor Penetration and Excellent Therapeutic Efficacy
Guangbao Yang et al.
ADVANCED MATERIALS (2019)
Registration of the extracellular matrix components constituting the fibroblastic focus in idiopathic pulmonary fibrosis
Jeremy Herrera et al.
JCI INSIGHT (2019)
Targeting Hypoxia-Inducible Factor-1 alpha/Pyruvate Dehydrogenase Kinase 1 Axis by Dichloroacetate Suppresses Bleomycin-induced Pulmonary Fibrosis
Justin Goodwin et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2018)
Extracellular Matrix Cross-Linking Enhances Fibroblast Growth and Protects against Matrix Proteolysis in Lung Fibrosis
Christopher J. Philp et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2018)
Chitosan-alginate nano-carrier for transdermal delivery of pirfenidone in idiopathic pulmonary fibrosis
Marzieh Abnoos et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2018)
Idiopathic Pulmonary Fibrosis
David J. Lederer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
HIF-1α triggers ER stress and CHOP-mediated apoptosis in alveolar epithelial cells, a key event in pulmonary fibrosis
Eva Delbrel et al.
SCIENTIFIC REPORTS (2018)
Matrix abnormalities in pulmonary fibrosis
Chandak Upagupta et al.
EUROPEAN RESPIRATORY REVIEW (2018)
Periostin regulates fibrocyte function to promote myofibroblast differentiation and lung fibrosis
S. L. Ashley et al.
MUCOSAL IMMUNOLOGY (2017)
Novel peptide probes to assess the tensional state of fibronectin fibers in cancer
Simon Arnoldini et al.
NATURE COMMUNICATIONS (2017)
Matrix stiffness regulates migration of human lung fibroblasts
Shuichi Asano et al.
PHYSIOLOGICAL REPORTS (2017)
Near-Infrared-Triggered Azobenzene-Liposome/Upconversion Nanoparticle Hybrid Vesicles for Remotely Controlled Drug Delivery to Overcome Cancer Multidrug Resistance
Chi Yao et al.
ADVANCED MATERIALS (2016)
Pirfenidone, nintedanib and N-acetylcysteine for the treatment of idiopathic pulmonary fibrosis: A systematic review and meta-analysis
Paola Rogliani et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2016)
Myofibroblasts Exhibit Enhanced Fibronectin Assembly That Is Intrinsic to Their Contractile Phenotype
Elizabeth E. Torr et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Carbon monoxide-bound hemoglobin-vesicles for the treatment of bleomycin-induced pulmonary fibrosis
Saori Nagao et al.
BIOMATERIALS (2014)
Effect of substrate stiffness on pulmonary fibroblast activation by TGF-β
H. N. Chia et al.
ACTA BIOMATERIALIA (2012)
Hypoxic enhancement of exosome release by breast cancer cells
Hamish W. King et al.
BMC CANCER (2012)
Albumin-based nanoparticles as potential controlled release drug delivery systems
Ahmed O. Elzoghby et al.
JOURNAL OF CONTROLLED RELEASE (2012)
New cellular and molecular mechanisms of lung injury and fibrosis in idiopathic pulmonary fibrosis
Isis E. Fernandez et al.
LANCET (2012)
Local delivery of biodegradable pirfenidone nanoparticles ameliorates bleomycin-induced pulmonary fibrosis in mice
Ruchit Trivedi et al.
NANOTECHNOLOGY (2012)
Effects of PEG size on structure, function and stability of PEGylated BSA
Bitten Plesner et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2011)
Influence of particle size on regional lung deposition - What evidence is there?
Thiago C. Carvalho et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2011)
Optimization of PEGylation Conditions for BSA Nanoparticles Using Response Surface Methodology
Hasan Kouchakzadeh et al.
AAPS PHARMSCITECH (2010)
NOX4/NADPH oxidase expression is increased in pulmonary fibroblasts from patients with idiopathic pulmonary fibrosis and mediates TGFβ1-induced fibroblast differentiation into myofibroblasts
Nadia Amara et al.
THORAX (2010)
The definition of fibrogenic processes in fibroblastic foci of idiopathic pulmonary fibrosis based on morphometric quantification of extracellular matrices
Masahiro Yamashita et al.
HUMAN PATHOLOGY (2009)
An essential role for fibronectin extra type III domain A in pulmonary fibrosis
Andres F. Muro et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases
Thomas A. Wynn
JOURNAL OF CLINICAL INVESTIGATION (2007)
Bone morphogenetic protein-4 inhibitor gremlin is overexpressed in idiopathic pulmonary fibrosis
Katri Koli et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
PEG-grafted chitosan as an injectable thermosensitive hydrogel for sustained protein release
N Bhattarai et al.
JOURNAL OF CONTROLLED RELEASE (2005)
Effect of pirfenidone on the pulmonary fibrosis of Hermansky-Pudlak syndrome
WA Gahl et al.
MOLECULAR GENETICS AND METABOLISM (2002)
Evidence for the role of alveolar epithelial gp60 in active transalveolar albumin transport in the rat lung
TA John et al.
JOURNAL OF PHYSIOLOGY-LONDON (2001)
Idiopathic pulmonary fibrosis: Prevailing and evolving hypotheses about its pathogenesis and implications for therapy
M Selman et al.
ANNALS OF INTERNAL MEDICINE (2001)
分享论文
